Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/24 16:50 | 6/13/23 | VNDA | Health | Drug | Pharmaceutical Preparations | Williams Timothy | DC | O | SVP,GC | 3 | S.m | -274 | 5.65 | 0 | -48 | 197 | D | |||||||||||||||
3/6/24 16:48 | 8/21/23 | VNDA | Health | Drug | Pharmaceutical Preparations | Wijkstrom Joakim | DC | O | SVP,CMO | 3 | S.m | -168 | 5.20 | 0 | -32 | 130 | D | |||||||||||||||
3/6/24 16:47 | 3/2/23 | VNDA | Health | Drug | Pharmaceutical Preparations | Polymeropoulos Mihael Hristos | DC | DOH | P,CEO | 2 | S.m | -512 | 5.11 | 0 | -100 | 1,872 | D | |||||||||||||||
3/6/24 16:46 | 7/28/23 | VNDA | Health | Drug | Pharmaceutical Preparations | Moran Kevin Patrick | DC | O | SVP,CFO, | 4 | S.m | -265 | 5.67 | 0 | -47 | 232 | D | |||||||||||||||
3/6/24 16:46 | 3/2/23 | VNDA | Health | Drug | Pharmaceutical Preparations | Birznieks Gunther | DC | O | SVP,Busi | 2 | S.m | -178 | 5.21 | 0 | -34 | 314 | D | |||||||||||||||
8/11/23 16:36 | 8/10/23 | VNDA | Health | Drug | Pharmaceutical Preparations | Mitchell Stephen Ray | DC | D | 1 | S | -39 | 6.05 | 0 | -7 | 29 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |